Yes, metabolic enzymes can be potential therapeutic targets. Inhibitors of specific enzymes can disrupt metabolic pathways crucial for the survival of cancer cells. For example, hexokinase inhibitors are being explored as potential cancer treatments. Understanding the role of these enzymes in cellular metabolism can thus contribute to the development of new therapies.
